Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betaxolol
Drug ID BADD_D00263
Description A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Indications and Usage For the management of hypertension.
Marketing Status approved; investigational
ATC Code C07AB05; S01ED02
DrugBank ID DB00195
KEGG ID D07526
MeSH ID D015784
PubChem ID 2369
TTD Drug ID D03ROX
NDC Product Code 42806-039; 24658-700; 42806-038; 24658-701
UNII O0ZR1R6RZ2
Synonyms Betaxolol | Betaxolol Hydrochloride | Hydrochloride, Betaxolol | Kerlone | Oxodal | Kerlon | SL-75212 | SL 75212 | SL75212 | ALO-1401-02 | ALO 1401 02 | ALO140102 | Betoptic | Betoptima | Betaxolol Alcon | Alcon, Betaxolol
Chemical Information
Molecular Formula C18H29NO3
CAS Registry Number 63659-18-7
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Angiopathy24.03.02.007--Not Available
Breast disorder21.05.04.004--Not Available
Cardiac disorder02.11.01.003--Not Available
Infestation11.09.01.001; 23.11.01.002--Not Available
Inflammation10.02.01.089; 08.01.05.007--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Conjunctival disorder06.06.02.004--Not Available
Erectile dysfunction19.08.04.001; 21.03.01.007--
Ill-defined disorder08.01.03.049--Not Available
Inner ear disorder04.04.02.002--Not Available
Lacrimal disorder06.08.02.005--Not Available
Sensation of foreign body08.01.09.002--Not Available
Psychotic disorder19.03.01.002--
Hyperlipidaemia14.08.03.001--
Renal impairment20.01.03.010--Not Available
Cystitis noninfective20.03.02.001--
Neuropsychological test abnormal13.07.06.001--Not Available
Oropharyngeal discomfort22.12.03.015; 07.05.05.008--Not Available
Oropharyngeal pain22.12.03.016; 07.05.05.004--
Anisocoria06.05.03.013; 17.02.11.009--Not Available
The 8th Page    First    Pre   8    Total 8 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene